Mechanism of Action:
Inhibits nicotinamide-N-methyltransferase (NNMT) enzyme
Increases NAD+ levels in cells
Activates mitochondrial biogenesis
Enhances fatty acid oxidation
Improves insulin sensitivity
Recommended for:
Patients with obesity and excess body weight
Individuals with metabolic syndrome
Age-related metabolism slowdown
Correction of lipid metabolism disorders
Insulin resistance
Research and Studies:
Preclinical studies show:
7-10% weight loss over 4 weeks
30-40% reduction in fat mass
50-70% increase in tissue NAD+ levels
Improved glucose tolerance
Activation of mitochondrial biogenesis in muscles
Obesity and excess body weight
Metabolic syndrome
Lipid metabolism disorders
Insulin resistance
Age-related metabolic disorders
The drug is dissolved in 1-2 ml of sterile water for injections and administered subcutaneously in the abdominal area. Recommended dosage is 500-1000 mcg once daily. Treatment course lasts 4-8 weeks with possible repetition after medical consultation.
Contraindications:
Pregnancy and lactation period
Severe liver and kidney diseases
Acute infectious diseases
Individual intolerance of components
Age under 18 years
Side Effects:
Redness at injection site
Mild nausea at course beginning
Headache
Allergic reactions